Conditions: Ocular Inflammation
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 400
Healthy volunteers: no

Brief summary:
To evaluate the clinical safety and efficacy of Loteprednol Etabonate Ophthalmic Ointment, 0.5% vs. vehicle for the treatment of inflammation following cataract surgery

Detailed description:

Arms:
arm 1: Loteprednol etabonate 0.5% ophthalmic ointment arm 2: Vehicle of loteprednol etabonate ointment

Interventions: intervention 1: 0.5% Loteprednol Etabonate Ophthalmic Ointment intervention 2: Vehicle of Loteprednol Etabonate Ophthalmic Ointment
Intervention descriptions: intervention 1: 1/2 inch ribbon four times a day for 14 days intervention 2: 1/2 inch ribbon four times a day for 14 days

Protocol document: